Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Mirion Technologies Inc (MIR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/07/2025: MIR (5-star) is a STRONG-BUY. BUY since 18 days. Simulated Profits (10.11%). Updated daily EoD!
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $31.29
1 Year Target Price $31.29
| 3 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 86.22% | Avg. Invested days 34 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 11/07/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.87B USD | Price to earnings Ratio 249.55 | 1Y Target Price 31.29 |
Price to earnings Ratio 249.55 | 1Y Target Price 31.29 | ||
Volume (30-day avg) 5 | Beta 0.93 | 52 Weeks Range 12.00 - 30.28 | Updated Date 11/9/2025 |
52 Weeks Range 12.00 - 30.28 | Updated Date 11/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-28 | When After Market | Estimate 0.02 | Actual 0.01 |
Profitability
Profit Margin 2.94% | Operating Margin (TTM) 3.77% |
Management Effectiveness
Return on Assets (TTM) 1.18% | Return on Equity (TTM) 1.61% |
Valuation
Trailing PE 249.55 | Forward PE - | Enterprise Value 5872876126 | Price to Sales(TTM) 7.62 |
Enterprise Value 5872876126 | Price to Sales(TTM) 7.62 | ||
Enterprise Value to Revenue 6.63 | Enterprise Value to EBITDA 28.87 | Shares Outstanding 244370206 | Shares Floating 214894392 |
Shares Outstanding 244370206 | Shares Floating 214894392 | ||
Percent Insiders 3.75 | Percent Institutions 91.41 |
Upturn AI SWOT
Mirion Technologies Inc
Company Overview
History and Background
Mirion Technologies, Inc. traces its roots back to various predecessor companies specializing in radiation detection and measurement. It was formally established in 2006 and has since grown through acquisitions and organic development to become a leading provider of radiation safety and measurement solutions.
Core Business Areas
- Dosimetry Services: Provides radiation monitoring and dosimetry services to individuals and organizations working with radioactive materials.
- Radiation Monitoring Systems: Offers fixed and portable radiation monitoring systems for nuclear power plants, hospitals, and other facilities.
- Health Physics Instruments: Develops and manufactures handheld and portable instruments for detecting and measuring radiation.
- Nuclear Measurement and Analysis: Designs and manufactures products and systems for nuclear measurement and analysis.
Leadership and Structure
Mirion Technologies is led by its CEO and a senior management team. The company operates with a functional organizational structure, with departments focused on sales, marketing, engineering, operations, and finance.
Top Products and Market Share
Key Offerings
- Instadose Dosimeters: A leading electronic personal dosimeter that provides instant dose readings and automated reporting. Market share is estimated to be significant in the dosimetry services market. Competitors include Landauer and Thermo Fisher Scientific.
- RDS-31 Survey Meter: A widely used handheld radiation survey meter for various applications. Its market share in handheld survey meters is substantial. Competitors include Ludlum Measurements and Fluke Biomedical.
- AccuRad Detectors: A portable radiation detection and identification instruments that provides instant dose readings. Competitors include Canberra and Thermo Fisher Scientific.
Market Dynamics
Industry Overview
The radiation detection and measurement industry is driven by regulations related to nuclear safety, medical imaging, and homeland security. Demand is influenced by the growth of nuclear power, medical applications of radiation, and concerns about radiological threats.
Positioning
Mirion Technologies is positioned as a leading provider of comprehensive radiation safety and measurement solutions. Its competitive advantages include a broad product portfolio, a strong brand reputation, and a global presence.
Total Addressable Market (TAM)
The global radiation detection and monitoring market is estimated to be several billion dollars. Mirion is well-positioned within this TAM, addressing key segments like nuclear power, medical, and defense.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Strong brand reputation
- Global presence
- Recurring revenue from dosimetry services
- Experienced management team
Weaknesses
- Exposure to cyclical industries (e.g., nuclear power)
- Dependence on regulatory approvals
- Integration risks from acquisitions
- High debt level
Opportunities
- Growth in emerging markets
- Increased demand for radiation monitoring in homeland security
- Development of new radiation detection technologies
- Expanding dosimetry services offerings
Threats
- Economic downturns
- Competition from established players
- Technological obsolescence
- Changes in regulations
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- THER (Thermo Fisher Scientific)
- CAE
- FLU (Fluke Corporation)
Competitive Landscape
Mirion Technologies competes with larger, diversified companies like Thermo Fisher Scientific and smaller, specialized firms. Mirion's advantage lies in its focus on radiation safety and measurement, allowing it to develop deep expertise and tailored solutions.
Major Acquisitions
Gems Rad Systems
- Year: 2022
- Acquisition Price (USD millions): 66
- Strategic Rationale: Expansion into new market segments, broadening the company's product portfolio in radiation detection and measurement.
Growth Trajectory and Initiatives
Historical Growth: Mirion Technologies has grown through acquisitions and organic expansion of its product line. Historical growth rates have varied depending on market conditions and acquisition activity.
Future Projections: Analysts project continued growth for Mirion Technologies, driven by increasing demand for radiation safety and measurement solutions.
Recent Initiatives: Recent initiatives include expanding into new markets, developing new products, and optimizing its operations.
Summary
Mirion Technologies is a leading provider in the radiation detection and measurement industry with a strong product portfolio and global presence. The company benefits from recurring revenue from dosimetry services but faces exposure to cyclical industries. Future growth is projected to be driven by increasing demand for radiation safety and measurement solutions, but the company must also be aware of economic downturns and technological obsolescence.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry Publications
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mirion Technologies Inc
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Chairman Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2860 | Website https://www.mirion.com |
Full time employees 2860 | Website https://www.mirion.com | ||
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.